Skip to main content
    D

    Diversified Healthcare Trust (DHC)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $7.10
    -0.12 (-1.73%)

    Market Cap: $1.75B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Diversified Healthcare Trust (DHC) Earnings: Report Dates and Results

    Updated Nov 2, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    FFO per share for Diversified Healthcare Trust (DHC) was $0.52 for 2025. In the quarter ended Sep 30, 2026, Diversified Healthcare Trust reported EPS of $0.13, below the $0.15 estimate. It beat the EPS estimate in 7 of the last 8 quarters. Diversified Healthcare Trust is expected to report earnings on Feb 22, 2027.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(19/40)
    Avg Surprise
    +1.05%

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    RangeN/A
    4 analysts
    Revenue Consensus
    $375.99M
    Range$355.74M - $401.25M
    6 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.13 - -$0.13
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.13-4.0%
    60d ago-$0.13-4.0%
    30d ago-$0.13-4.0%
    7d ago-$0.13-4.0%
    Current-$0.13
    Revenue Consensus
    $379.08M
    Range$369.00M - $385.74M
    5 analysts

    Next Report

    DHC has an expected report date of Feb 22, 2027.

    DHC Earnings Call

    The latest DHC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, DHC beat 19, missed 19 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $367.67M, down 5.4% from $388.71M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.13$0.15N/A-13.33%MissN/A11 up, 0 downNov 2, 2026$367.67M
    Jun 30, 2026$0.16$0.14N/A+14.29%BeatN/A21 up, 0 downAug 3, 2026$365.39M
    Mar 31, 2026-$0.13-$0.16-$0.17 - -$0.15+18.75%BeatN/A30 up, 0 downMay 4, 2026$366.47M
    Dec 31, 2025-$0.06-$0.18-$0.18 - -$0.18+65.06%BeatN/A11 up, 0 downFeb 23, 2026$379.57M
    Sep 30, 2025-$0.22-$0.23-$0.23 - -$0.23+4.35%BeatN/A10 up, 1 downNov 3, 2025$388.71M
    Jun 30, 2025-$0.20-$0.23-$0.23 - -$0.23+13.04%BeatN/A11 up, 0 downAug 4, 2025$382.71M
    Mar 31, 2025-$0.24-$0.28-$0.28 - -$0.28+14.29%BeatN/A10 up, 0 downMay 5, 2025$386.86M
    Dec 31, 2024-$0.27-$0.29-$0.29 - -$0.29+6.55%BeatN/A10 up, 1 downFeb 25, 2025$379.62M
    Sep 30, 2024-$0.41-$0.26N/A-58.38%MissN/AN/A0 up, 0 downNov 4, 2024$373.64M
    Jun 30, 2024-$0.32-$0.28-$0.28 - -$0.28-14.29%MissN/A10 up, 0 downAug 1, 2024$371.39M
    Mar 31, 2024-$0.28-$0.28-$0.28 - -$0.280.00%In lineN/A10 up, 0 downMay 6, 2024$370.78M
    Dec 31, 2023-$0.43-$0.25-$0.25 - -$0.25-72.00%MissN/A10 up, 0 downFeb 26, 2024$361.54M
    Sep 30, 2023-$0.28-$0.20N/A-40.00%MissN/AN/A0 up, 0 downNov 1, 2023$356.52M
    Jun 30, 2023-$0.30-$0.22N/A-36.36%MissN/A10 up, 0 downAug 1, 2023$346.22M
    Mar 31, 2023-$0.22-$0.23-$0.23 - -$0.23+4.35%Beat-121.6%20 up, 0 downMay 8, 2023$346.03M
    Dec 31, 2022-$0.25-$0.28-$0.28 - -$0.24+10.71%BeatN/A20 up, 0 downMar 1, 2023$336.88M
    Sep 30, 2022-$0.31-$0.23N/A-34.78%MissN/A20 up, 0 downNov 2, 2022$322.92M
    Jun 30, 2022-$0.33-$0.29N/A-13.79%MissN/AN/A0 up, 0 downAug 3, 2022$313.03M
    Mar 31, 2022$1.02$1.04N/A-1.92%MissN/A20 up, 0 downMay 3, 2022$310.73M
    Dec 31, 2021-$0.40-$0.24-$0.24 - -$0.24-66.67%MissN/A1N/AFeb 23, 2022$336.73M
    Sep 30, 2021-$0.30-$0.24-$0.24 - -$0.22-25.00%MissN/A2N/ANov 3, 2021$337.42M
    Jun 30, 2021-$0.22-$0.23N/A+4.35%Beat-1200.0%3N/AAug 4, 2021$346.34M
    Mar 31, 2021-$0.28-$0.23-$0.25 - -$0.20-21.74%Miss-800.0%3N/AMay 5, 2021$362.72M
    Dec 31, 2020-$0.07-$0.22-$0.24 - -$0.20+68.18%Beat-333.3%3N/AFeb 24, 2021$384.91M
    Sep 30, 2020-$0.21-$0.12N/A-75.00%Miss-2200.0%4N/ANov 5, 2020$394.34M
    Jun 30, 2020$0.02-$0.16-$0.23 - $0.01+112.50%Beat-60.0%4N/AAug 6, 2020$410.31M
    Mar 31, 2020$0.04-$0.08-$0.28 - $0.06+150.00%Beat-55.6%3N/AMay 7, 2020$442.47M
    Dec 31, 2019$0.03$0.03$0.02 - $0.050.00%In lineN/A3N/AMar 2, 2020$256.04M
    Sep 30, 2019$0.01$0.02N/A-50.00%Miss-92.9%N/AN/ANov 7, 2019$255.83M
    Jun 30, 2019$0.05$0.07N/A-28.57%Miss-68.8%N/AN/AAug 8, 2019$262.00M
    Mar 31, 2019$0.09$0.10N/A-10.00%Miss-89.8%N/AN/AMay 9, 2019$266.29M
    Dec 31, 2018-$0.50$0.16N/A-412.50%Miss-327.3%N/AN/AMar 1, 2019$285.22M
    Sep 30, 2018$0.14$0.12N/A+16.67%Beat-22.2%N/AN/ANov 6, 2018$278.97M
    Jun 30, 2018$0.16$0.14N/A+14.29%Beat+14.3%N/AN/AAug 7, 2018$277.20M
    Mar 31, 2018$0.88$0.16N/A+450.00%Beat+528.6%N/AN/AMay 9, 2018$275.77M
    Dec 31, 2017$0.22$0.16N/A+37.50%Beat+22.2%N/AN/AFeb 27, 2018$278.48M
    Sep 30, 2017$0.18$0.16N/A+12.50%Beat+28.6%N/AN/ANov 9, 2017$266.67M
    Jun 30, 2017$0.14$0.15N/A-6.67%Miss-17.6%N/AN/AAug 3, 2017$265.01M
    Mar 31, 2017$0.14$0.15N/A-6.67%Miss-12.5%N/AN/AMay 5, 2017$264.56M
    Dec 31, 2016$0.18$0.16N/A+12.50%Beat-10.0%N/AN/AFeb 27, 2017$274.30M
    Last 40 quarters

    Annual FFO

    FFO per share was $0.52 for 2025, up 92.6% from $0.27 in 2024. It was $1.84 for 2016, the oldest of the 10 years shown.

    Fiscal yearFFO per shareChange
    2025$0.52+92.6%
    2024$0.27N/A
    2023-$0.16N/A
    2022-$0.03N/A
    2021$0.67-48.9%
    2020$1.31-17.6%
    2019$1.59+0.6%
    2018$1.58-16.0%
    2017$1.88+2.2%
    2016$1.84N/A

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.72, after -$1.28 the year before. It was $0.65 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.72N/A
    Dec 31, 2024-$1.28N/A
    Dec 31, 2023-$1.23-1046.2%
    Dec 31, 2022$0.13N/A
    Dec 31, 2021-$1.20N/A
    Dec 31, 2020-$0.22-222.2%
    Dec 31, 2019$0.18-73.5%
    Dec 31, 2018$0.68N/A
    Dec 31, 2017$0.68N/A
    Dec 31, 2016$0.65N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,800 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20263,7956
    2026Q2Jun 30, 20263,4647
    2026Q1Mar 31, 20263,6747
    2025Q4Dec 31, 20254,1668
    2025Q3Sep 30, 20253,4106
    2025Q2Jun 30, 20253,4677
    2025Q1Mar 31, 20253,2827
    2024Q4Dec 31, 20243,4997

    2026Q3 Earnings Call

    Opening remarks

    Matt Murphy Manager of Investor Relations Good morning. Joining me on today's call are Christopher J. Bilotto, President and Chief Executive Officer, and Matthew C. Brown, Chief Financial Officer and Treasurer. Today's call includes a presentation by management followed by a question-and-answer session with sell-side analysts. Please note that the recording and retransmission of today's conference call are strictly prohibited without the prior written consent of the company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 2002 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations as of today, Tuesday, November 3, 2026. The company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call, other than through filings with the Securities and Exchange Commission, or SEC. Actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. In addition, this call may contain non-GAAP numbers, including normalized funds from operations, or normalized FFO; net operating income, or NOI; cash-basis net operating income, or cash-basis NOI; and Adjusted EBITDAre. A reconciliation of these non-GAAP measures to net income is available in our financial results package, which can be found on our website at www.dhcreit.com. Beginning this quarter, our calculations of normalized FFO and Adjusted EBITDAre include estimated incentive management fees accrued under GAAP, and prior periods have been recast to conform to this presentation. Finally, we will be providing guidance on this call, including NOI. We are not providing a reconciliation of these non-GAAP measures as part of our guidance because certain information required for such a reconciliation is not available without unreasonable effort or at all, such as gains and losses or impairment charges related to the disposition of real estate. With that, I would now like to turn the call over to Christopher.

    Christopher J. Bilotto President and Chief Executive Officer Thank you, Matthew. Good morning, everyone. Thank you for joining our call today. Our third-quarter results reflect continued execution on the strategy we have laid out for the year. That strategy shows up across stronger operating results in our SHOP portfolio, active optimization of how we own and operate individual assets, and a steadily improving financial profile. Following the market close yesterday, DHC reported normalized FFO of $30.7 million, or $0.13 per share, and Adjusted EBITDAre of $73.4 million, an increase of 28.4% year over year. Same-property cash-basis NOI increased 25.6% to $77.9 million, and consolidated NOI increased 27.5% to $80.8 million. Before going further, I want to note a change in our presentation.

    Frequently Asked Questions About DHC

    When is Diversified Healthcare Trust's next earnings date?

    Diversified Healthcare Trust's next earnings report is expected for Feb 22, 2027.

    Did DHC beat earnings estimates last quarter?

    No. Diversified Healthcare Trust reported EPS of $0.13 for the quarter ended Sep 30, 2026, below the $0.15 estimate by 13.33%.

    What EPS do analysts expect from DHC next quarter?

    The consensus EPS estimate for Diversified Healthcare Trust for the quarter ending Dec 31, 2026 is -$0.14 from 4 analysts.

    How often does DHC beat earnings estimates?

    Diversified Healthcare Trust beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +15.37%.